The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

about

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

Item

http://www.wikidata.org/entity/Q38760559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

@en

type

Item

label

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

@en

prefLabel

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

@en

P1476

The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients

@en

P2093

Burabha Pussadhamma

http://www.w3.org/2001/XMLSchema#string

Chaiyasith Wongvipaporn

http://www.w3.org/2001/XMLSchema#string

Pattarapong Makarawate

http://www.w3.org/2001/XMLSchema#string

Songsak Kiatchoosakun

http://www.w3.org/2001/XMLSchema#string

Suda Vannaprasaht

http://www.w3.org/2001/XMLSchema#string

Sutthida Kaewmoongkun

http://www.w3.org/2001/XMLSchema#string

Wichittra Tassaneeyakul

http://www.w3.org/2001/XMLSchema#string

P2860

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

CYP2C9 allelic variants: ethnic distribution and functional significance

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement

Common VKORC1 and GGCX polymorphisms associated with warfarin dose.

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

CYP4F2 genetic variant alters required warfarin dose

P2888

s00228-017-2265-8

P304

973-980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-017-2265-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nitsupa Wattanachai

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085592277

http://www.w3.org/2001/XMLSchema#string

P698

28550460

http://www.w3.org/2001/XMLSchema#string

P932

5508045

http://www.w3.org/2001/XMLSchema#string